Five cases of anthracycline-induced cardiomyopathy effectively treated with carvedilol

被引：21

作者：

Mukai, Y

Yoshida, T

Nakaike, R

Mukai, N

Iwato, K

Kyo, T

Kaseda, S

机构：

[1] Hiroshima Red Cross & Atom Bomb Survivors Hosp, Div Cardiol, Naka Ku, Hiroshima 7308619, Japan

[2] Hiroshima Red Cross & Atom Bomb Survivors Hosp, Internal Med Div 4, Hiroshima 7308619, Japan

来源：

INTERNAL MEDICINE | 2004年 / 43卷 / 11期

关键词：

anthracycline-induced cardiomyopathy; chronic heart failure; beta-blocker; carvedilol;

D O I：

10.2169/internalmedicine.43.1087

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Anthracycline, a widely used anti-cancer agent, can elicit irreversible cardiomyopathy called anthracycline-induced cardiomyopathy (ACM). In this report, we describe 5 cases of severe chronic heart failure due to ACM effectively treated with the beta-blocker, carvedilol. Their left ventricular function as well as cardiac symptoms were persistently improved after treatment with carvedilol, suggesting that carvedilol may be an effective therapeutic strategy for ACM as demonstrated in other forms of chronic heart failure.

引用

页码：1087 / 1088

页数：2

共 5 条

[1] Doxorubicin-induced cardiomyopathy treated with carvedilol [J].